Related Experiment Video
Updated: Feb 9, 2026

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
Cervical cancer is addicted to SIRT1 disarming the AIM2 antiviral defense
Daeho So1,2,3, Hyun-Woo Shin1,2,3, Jiyoung Kim1,2,3
1Department of Biomedical Science, Seoul National University College of Medicine, Daehak-ro, Jongno-gu, Seoul, 03080, Korea.
Abstract:
Mammalian cells are equipped with antiviral innate immunity. To survive and grow, human papilloma virus (HPV)-infected cervical cancer cells must overcome this host defense system. However, the precise mechanism whereby cervical cancer cells evade the immunity is not fully understood. We noted that Sirtuin 1 (SIRT1) is overexpressed in HPV-infected cervical cancer cells and hypothesized that SIRT1 counteracts antiviral immunity. Here, we found that cervical cancer cells undergo massive death by SIRT1 knockdown, but this effect is reversed by SIRT1 restoration. SIRT1-knocked-down cells showed representative features of pyroptosis, as well as highly expressed absent in melanoma 2 (AIM2) and its downstream genes related to the inflammasome response. Mechanistically, SIRT1 repressed the NF-κB-driven transcription of the AIM2 gene by destabilizing the RELB mRNA. Interestingly, pyroptotic death signaling in SIRT1-knocked-down cells was transmitted to naïve cervical cancer cells, which was mediated by extracellular vesicles carrying AIM2 inflammasome proteins. Furthermore, the growth of cervical cancer xenografts was significantly inhibited by either SIRT1-targeting siRNAs or SIRT1-knockdown-derived extracellular vesicles. Immunohistochemical analyses showed that SIRT1 expression correlated with poor clinical outcomes in cervical cancer. In conclusion, SIRT1 enabled HPV-infected cervical cancer cells to continue growing by nullifying AIM2 inflammasome-mediated immunity. Without SIRT1, cervical cancer cells could no longer survive because of the derepression of the AIM2 inflammasome. SIRT1 could therefore be a target for the effective treatment of cervical cancer.
Insights
Sirtuin 1 (SIRT1) enables human papillomavirus (HPV)-infected cervical cancer cells to evade antiviral immunity by suppressing the AIM2 inflammasome. Inhibiting SIRT1 triggers pyroptosis and halts tumor growth, suggesting SIRT1 as a therapeutic target.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Mammalian cells possess innate antiviral immunity, a defense system that human papillomavirus (HPV)-infected cervical cancer cells must overcome to proliferate.
- The mechanisms by which cervical cancer cells evade host antiviral immunity are not fully elucidated.
- Sirtuin 1 (SIRT1) is observed to be overexpressed in HPV-infected cervical cancer cells, prompting investigation into its role in immune evasion.
Purpose of the Study:
- To investigate the role of Sirtuin 1 (SIRT1) in the immune evasion strategies of human papillomavirus (HPV)-infected cervical cancer cells.
- To determine if SIRT1 counteracts antiviral innate immunity in cervical cancer.
- To explore the therapeutic potential of targeting SIRT1 in cervical cancer treatment.
Main Methods:
- SIRT1 knockdown and restoration experiments in cervical cancer cells.
- Analysis of pyroptosis markers, inflammasome components (AIM2), and downstream signaling pathways.
- Investigation of SIRT1's mechanism involving NF-κB, RELB mRNA destabilization, and extracellular vesicle-mediated signaling.
- Assessment of SIRT1-targeting siRNAs and extracellular vesicles in cervical cancer xenograft models.
- Immunohistochemical analysis of SIRT1 expression in clinical cervical cancer samples.
Main Results:
- SIRT1 knockdown induced massive cell death in cervical cancer cells, characterized by pyroptosis and upregulation of AIM2 inflammasome components.
- SIRT1 was found to repress NF-κB-driven AIM2 transcription by destabilizing RELB mRNA.
- Extracellular vesicles carrying AIM2 inflammasome proteins mediated the transmission of pyroptotic death signals to neighboring cancer cells.
- SIRT1 inhibition, via siRNAs or extracellular vesicles, significantly suppressed cervical cancer xenograft growth.
- Elevated SIRT1 expression correlated with poorer clinical outcomes in cervical cancer patients.
Conclusions:
- SIRT1 facilitates the survival and growth of HPV-infected cervical cancer cells by suppressing AIM2 inflammasome-mediated antiviral immunity.
- The absence of SIRT1 leads to the derepression of the AIM2 inflammasome, resulting in cancer cell death.
- SIRT1 represents a promising therapeutic target for the effective treatment of cervical cancer.
Related Concept Videos
Defenses Against Pathogens and Herbivores
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Defense Mechanism Against Infection
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
Drug Abuse and Addiction: Pharmacological Phenomena
The Antiviral System of Bacteria and Archaea: CRISPR
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

